Skip to content

Effect of cereal-derived processed product on metabolism :a randomized, double-blind, crossover study

Effect of cereal-derived processed product on metabolism :a randomized, double-blind, crossover study - Effect of cereal-derived processed product on metabolism

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000024510
Enrollment
15
Registered
2016-10-24
Start date
2016-10-24
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy humans

Interventions

Intake of control food (one time) Intake of test food (one time)

Sponsors

Kao Corporation
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1. Age<65 of healthy men and menopause women 2. 23<=BMI<30 3. provided written informed consent from subjects

Exclusion criteria

Exclusion criteria: 1; suffering from liver, kidney, heart disease, disorder respiration endocrine, metabolism, nervous system consciousness, diabetes, or other diseases 2; LDL-cholesterol>=140mg/dL, triglyceride>=150mg/dL, Systolic blood pressure>=140mmHg, diastolic pressure>=90mmHg, fasting blood glucose>=126mg/dL, 3; taking medication or operation by severe sickness and injury within 2 months before the trial, 4; becoming unpleasant feeling after blood test or energy expenditure analyzing (metabolic chamber, collecting of breath by mask or hood) 5; making blood donation of 200 mL or more within l month of this trial 6; medicine user for hyperglycemia, hyperlipidemia, or hypertension, 7; unstable measurement of energy expenditure 8; heavy drinker(more than 30 g/day alcohol everyday) 9; user of supplements or foods with health claim 10; having variability in body weight more than +-2.0 kg within 1 month of this trial 11; business trip or travel planned for 5 consecutive days or more during this trial 12; having allergy to gum 13; having allergy to the ingredients included in the test meal 14; smoker 15; participating subject of other clinical study or having a plan during this study period, 16; judged to be inappropriate for the study based on the access record by medical doctor. 17; judged to be inappropriate as subject by physician in charge

Design outcomes

Primary

MeasureTime frame
Fat oxidation

Secondary

MeasureTime frame
Serum glucose-dependent insulinotropic polypeptide and insulin. Energy expenditure

Countries

Japan

Contacts

Public ContactChizuka Suzuki

Kao Corporation Health Care Food Research Labs

suzuki.chizuka@kao.co.jp03-5630-7456

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026